Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in adults with persistent asthma: effects on airway inflammation
2015-001572-22Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Dupilumab with Placebo (2 arms). Primary endpoint: Change in bronchial submucosal inflammatory cells. Started Aug 2015; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-001572-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001572-22.